Study Backs Chemo For Lung Cancer; Finds Cisplatin-Based Therapy Increases Survival After Surgery
European researchers are reporting the first evidence that chemotherapy after surgery can improve the chances of survival for people with lung cancer. To an untrained eye, the increased survival rate does not appear striking. Of the 932 patients who had chemotherapy after the cancer was removed surgically, 44.5 percent were alive after an average of 56 months, compared to 40.4 percent of the 932 patients who did not receive the drug treatment, says a report in the Jan. 22 issue of the New England Journal of Medicine. The research was conducted by the International Adjuvant Lung Cancer Trial Collaborative Group.